Can a female of reproductive age with an endometrium thickness of 9.3 mm on day 11 of her menstrual cycle, currently taking 6mg of unspecified medication, start a new medication for a Frozen Embryo Transfer (FET) cycle?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Start Progesterone for FET with Endometrial Thickness of 9.3mm on Day 11?

Yes, you can start progesterone for the FET cycle with an endometrial thickness of 9.3mm on day 11, as this falls within the optimal range associated with the highest pregnancy success rates in frozen embryo transfer cycles. 1

Optimal Endometrial Thickness for FET

Your patient's endometrial thickness of 9.3mm is ideal for proceeding with progesterone supplementation and frozen embryo transfer:

  • The optimal endometrial thickness range for FET cycles is 9-14mm, measured on the day of progesterone supplementation 1
  • Endometrial thickness of 9-14mm is associated with significantly higher implantation rates (19% vs 12%), clinical pregnancy rates (30% vs 18%), ongoing pregnancy rates (27% vs 16%), and live birth rates (25% vs 14%) compared to thickness of 7-8mm 1
  • These superior outcomes remain statistically significant even after adjusting for confounding variables, with an adjusted odds ratio of 1.83 for clinical pregnancy, 1.8 for ongoing pregnancy, and 1.9 for live birth 1

Timing Considerations

The timing is appropriate for your patient on day 11 of the cycle:

  • In medicated FET protocols using 6mg oral estradiol valerate (started on menstrual day 1), progesterone supplementation (800mg daily pessaries) should be initiated when endometrial thickness reaches ≥7mm 1
  • Embryo transfer typically occurs 2-3 days after progesterone initiation 1
  • Your patient has already achieved the optimal thickness range (9.3mm), so progesterone can be started immediately 1

Evidence Quality and Clinical Implications

  • The threshold of 9mm represents a clinically meaningful cutoff, with pregnancy rates increasing gradually from 53% in patients with endometrial thickness <9mm to 77% in those with thickness ≥16mm 2
  • Clinical pregnancy and live birth rates increase significantly with increasing endometrial thickness, independent of patient age and embryo quality 2
  • However, be aware that some recent critical appraisals suggest that many retrospective studies on endometrial thickness do not adequately address confounding factors, though the preponderance of evidence still supports using these thresholds for clinical decision-making 3

Common Pitfalls to Avoid

  • Do not delay progesterone initiation waiting for further endometrial thickening beyond 9mm, as your patient is already in the optimal range 1
  • Avoid using endometrial thickness <7mm as a threshold to proceed, as this is associated with significantly lower pregnancy rates 1
  • Be cautious with endometrial thickness >14mm, as very thick endometrium (>16mm) may be associated with other considerations, though pregnancy rates remain favorable 2

Related Questions

What are the implications of an endometrium thickness of 1.7cm and how should it be managed?
What is the best course of action to evaluate and manage pelvic pain and a thickened endometrium in a 33-year-old female, 8 months postpartum, without abnormal uterine bleeding?
What is the recommended next step in management for a patient with an endometrium thickness of 1.64 cm?
What alternatives to ormeloxifene (Centchroman) can be considered for a 42-year-old woman with Paroxysmal Supraventricular Tachycardia (PSVT) and Abnormal Uterine Bleeding (AUB) who has a thickened endometrium, and does she require an endometrial biopsy?
Is a 14mm thick uterus with a very light period for only 2 days normal and what investigations should be done?
What are the alternative treatment options for ocular toxoplasmosis in an immunocompromised patient when pyrimethamine and sulfadiazine are not available?
What is the best course of action for a patient experiencing persistent headache and vomiting, with potential underlying conditions such as meningitis, encephalitis, or brain tumor?
What is the next step in evaluating an adult patient with leukopenia, small lymphadenopathy, and normal differential counts, with all other blood profiles being normal?
What are the next steps for an asymptomatic individual with a low likelihood of Mycobacterium tuberculosis infection who has a positive Quantiferon-TB Gold Plus test result?
Can prednisone (corticosteroid) cause dizziness and tinnitus (ringing in the ear) in patients?
What are the primary medication options for a female patient with Polycystic Ovary Syndrome (PCOS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.